Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines
Clinical trial NCT02568150 · COMPLETED
Trial details
- NCT number
- NCT02568150
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.